stock.name

Geron Corp.

GERN

Market Cap$2.3B
Close$

Compare Geron

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Geron Corp.Geron Corp.-11.40%-58%-0.2
marketMarket Avg54.31.27%32%-1.3
HealthcareHealthcare Avg39.11.36%17%7.21.3
$4.83

Target Price by Analysts

29.2% upsideGeron Target Price DetailsTarget Price
$-0.03

Current Fair Value

100.9% downside

Overvalued by 100.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.30 Billion
Enterprise Value$1.94 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.34
Beta0.0
Outstanding Shares593,132,540
Avg 30 Day Volume11,002,233

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-11.43
PEG-25.23
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue3732.79
Enterprise Value to EBIT-9.24
Enterprise Value to Net Income-10
Total Debt to Enterprise0.04
Debt to Equity0.24

Revenue Sources

No data

ESG Score

No data

About Geron Corp.

CEO: John Scarlett